Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thar Instruments was a global leader in the design, development, and manufacture of Supercritical Fluid Chromatography (SFC) systems. The company's technology provided a green alternative to traditional liquid chromatography by using carbon dioxide as the primary mobile phase, significantly reducing solvent consumption and waste. Their products were widely adopted in the pharmaceutical industry for chiral and achiral separations, purification, and analytical applications. In 2009, the company was acquired by Waters Corporation, which integrated Thar's SFC portfolio into its broader suite of analytical tools and laboratory solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thar Instruments.